Evolution of Poliovirus Type I during 5.5 Years of Prolonged Enteral Replication in an Immunodeficient Patient  by Bellmunt, Andreas et al.
p
t
t
p
i
(
t
c
g
n
r
(
l
d
e
d
n
r
r
s
c
p
d
C
5
G
Virology 265, 178–184 (1999)
Article ID viro.1999.0003, available online at http://www.idealibrary.com on
0
C
ARAPID COMMUNICATION
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in an Immunodeficient Patient
Andreas Bellmunt,* Gu¨nter May,† Roland Zell,‡ Patricia Pring-Åkerblom,* Willem Verhagen,* and Albert Heim*,1
*Institut fu¨r Virologie, Medizinische Hochschule, Hannover, Germany; †Abteilung Virologie,2 Institut fu¨r Mikrobiologie, Universita¨t Mu¨nster,
Mu¨nster, Germany; and ‡Institut fu¨r Virologie, Friedrich Schiller Universita¨t Jena, Jena, Germany
Received June 29, 1999; returned to author for revision August 10, 1999; accepted September 10, 1999
Poliovirus type 1 was isolated from an immunodeficient patient 4 days after onset of paresis (IS1) and after 5.5 years of
prolonged enteral virus replication (IS2). Antigenic characterization revealed that IS1 was Sabin 1-like, whereas IS2 reacted
like poliovirus 1 Mahoney. Complete genomic sequencing demonstrated the phylogenetic relationship (94.9% identity) of IS1
and IS2, which differed from the most closely related Sabin 1 by 5.4 and 8.3%, respectively. Both isolates had revertant-like
mutations at nucleotides 480 and 6203. Deduced amino acid sequences indicated significant changes between IS1 and IS2
at the neutralizing antigenic site 1. Prolonged enteral replication, evolution, and shedding of poliovirus by immunodeficient
patients should be considered in the poliovirus eradication strategy. © 1999 Academic Press
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sIntroduction. Humans are the only natural reservoir for
oliovirus, which usually causes acute infections and is
ransmitted only by infected persons or by contact with
heir excretions (2, 6). Oral poliovirus vaccine (OPV) is
referred for poliovirus eradication because it induces
ntestinal immunity in addition to neutralizing antibodies
6), is easier to handle, and is less expensive than inac-
ivated poliovirus vaccine. However, OPV is contraindi-
ated in immunodeficient individuals with hypogamma-
lobulinemia, for example, with common variable immu-
odeficiency syndrome (CVID), because of an increased
isk of vaccine-associated paralytic poliomyelitis (VAPP)
6). As CVID is usually not diagnosed in the first year of
ife, CVID patients are frequently vaccinated with OPV
uring routine vaccination schedules. Prolonged virus
xcretion was described in a few CVID patients after
iagnosis of VAPP (6, 19). In addition to an insufficient
eutralizing antibody response, an increased chance of
eversion to neurovirulence during prolonged intestinal
eplication may contribute to the development of paraly-
is in CVID patients (8). Hence, prolonged enteral repli-
ation and shedding of poliovirus may be a threat to the
oliovirus eradication efforts.
Here we report the complete sequencing of two polio-
1 To whom correspondence and reprint requests should be ad-
ressed at Institut fu¨r Virologie, Medizinische Hochschule Hannover,
arl-Neuberg-Strasse 1, D-30625 Hannover, Germany. Fax: 149-511-
325732. E-mail: ahei@virologie.mh-hannover.de.
2 National Poliovirus Reference Laboratory of the Federal Republic of
termany until 1991.
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178irus isolates obtained from a CVID patient just after
nset of paralysis and after 5.5 years of continuous virus
xcretion demonstrating evolutionary changes toward a
wild-type-like” genotype. Combined anamnestic and
volutionary data indicated about 10 years of persistent
nteral poliovirus replication.
Results. Characterization of isolates. Fourty-four iso-
ates were obtained from the index patient during a
eriod of 5.5 years and were typed as polio 1 by neu-
ralization tests. Intratypic differentiation (van Wezel
ethod) revealed that the first isolate (IS1) from a throat
ash had “vaccine-like” properties, whereas poliovirus
solated from feces on the same day and all later isolates
ere “non-vaccine-like”. Restriction fragment length anal-
sis of partial sequences as proposed by Balanant et al.
3) revealed that the DdeI fragment pattern of IS1 was
dentical to that of Sabin 1 (cutting position 2763). The
estriction fragment patterns for HpaII (no digestion) and
aeIII (cutting positions 2583 and 2632) were identical to
hose of poliovirus 2 Lansing strain. For IS2, the HaeIII
ragment pattern was identical with the poliovirus I Ma-
oney strain (cutting position 2632), whereas analysis
uggested no digestion with HpaII, similar to poliovirus
. The DdeI fragment length analysis of IS2 (cutting
ositions 2594 and 2763) showed an atypical pattern
ompared to all poliovirus 1 to 3 prototype strains. Direct
equencing of polymerase chain reaction (PCR) ampli-
ons was performed in order to obtain the most repre-
entative sequence of the replicating poliovirus popula-ion. Significant sequence ambiguities were not ob-
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179RAPID COMMUNICATIONerved, obviously due to this strategy and small
noculum sizes. However, two virus populations were
resent 4 days after onset of symptoms as indicated by
ivergent antigenic subtyping of the throat wash isolate
IS1) and an isolate from feces obtained on the same day.
Phylogenetic Analysis. Alignments of the complete
enomic sequences with the EMBL databank sequences
evealed that IS1 and IS2 had the highest level of identity
o the Sabin 1 strain (V01150), 94.6 and 91.7%, respec-
ively. Identity of IS1 and IS2 to the databank sequence of
oliovirus 1 Mahoney strain (J02281) was slightly lower,
4.4 and 91.0%, respectively. Both IS1 and IS2 had a
ingle base insertion at nucleotide position 115, which is
nique in comparison to poliovirus type 1 databank se-
uences. Moreover, a multiple alignment demonstrated
common sequence of IS1 and IS2 at 19 nucleotide
ositions that was divergent from all poliovirus 1 data-
ank sequences. Phylogenetic analysis of both isolates
nd prototype strains was performed comparing the
omplete genomic sequences, the 59 nontranslated re-
ion (59NTR) sequences, and the deduced amino acid
equences. Phylogenetic trees confirmed that IS1 and
S2 are closely related to each other and more closely to
oliovirus 1 than to poliovirus 2 and 3 (Figs. 1A, 1B, and
C). Phylogenetic analysis and bootstrapping of a 150-bp
ragment of the VP1/2A junction, proposed previously for
enotyping of poliovirus isolates (13, 14), indicated a
loser phylogenetic relationship of both isolates to the
abin 1 strain than to polio 1 wild-type isolates from
arious regions of the world (Fig. 1D). Both IS1 and IS2
ad reverted to the wild-type sequence at nt 21, 26, 355,
80, 935, 1442, 1944, 2775, 2795, 3445, 4116, 5107, 6143,
203, 6734, and 7071 (nucleotide positions according to
he Sabin 1 sequence). IS2 had additionally reverted at nt
49 and nt 4444, indicating a continuing tendency of
enetic change toward the Mahoney wild-type strain.
An evolution rate of 9.7 3 1023 (per year and nucleo-
ide) was calculated from the complete genomic se-
uences of IS1 and IS2 by the two-parameter method
10). It was estimated that the patient had been infected
.4 years before onset of symptoms and isolation of IS1,
ssuming that the evolution rate per year and nucleotide
as constant and IS1 descended from the Sabin 1 vac-
ine strain. In order to exclude a positive selection, the
volutionary distances were also calculated from third-
odon position substitutions of the VP1/2A region, which
esulted only in synonymous amino acid mutations, and
rom sequence data of the nt 640–743 region, which is
oth noncoding and presumably lacks any conserved
NA secondary structures. Thus, the time from initial
nfection to the first isolation of poliovirus was estimated
o be 7.7 and 4.2 years, respectively.
59NTR RNA Secondary Structures. When compared to
he genome of poliovirus type 1 Sabin, the 59NTRs of IS1
nd IS2 exhibit 48 and 57 nucleotide exchanges, respec- eively. For both isolates, mutations in the sequence con-
ext of the putative secondary structures II and IV allow
he formation of two additional base pairs in each do-
ain, resulting in an increase of the calculated free
nergy (Fig. 2). However, most nucleotide exchanges
IS1, 79%; IS2, 89%) were observed in genome positions
upposed to be single-stranded, i.e., the loops and
ulges of the secondary structures and the stretch of
pproximately 100 nucleotides between the last pre-
icted RNA domain and the start codon. None of the
utations within the double-stranded regions of the RNA
omains disrupted predicted base pairings.
Deduced Amino Acid Sequences. Mutations resulted
n 9 amino acid substitutions restoring the wild-type
equence in both IS1 and IS2. Moreover, 47 amino acid
ubstitutions were observed between IS1 and IS2. The
ighest frequency of amino acid changes was noted in
he virion protein (VP) 4 region, the P2A region, and the
P1 region, whereas the deduced amino acid sequences
f the proteins P2B, P3D, and P3B were highly conserved
Table 1). A hot spot of amino acid substitutions was
bserved at the neutralizing antigenic site 1 (NAg I). Only
ne of three amino acid substitutions in the NAg I site
estored the Mahoney strain sequence in IS1, and all four
ubstitutions of IS2 did not restore the Mahoney strain
equence (Fig. 3). The VP1 parts of the complex Nag II
nd NAg III were completely conserved (Fig. 3), and
here were only minor changes in the VP2 part of NAg II
one amino acid substitution in IS2, A2171T) and the VP3
art of NAg III (both IS1 and IS2 had a revertant-like K at
mino acid residue 3060, and one substitution, R3071Q,
ompared to the identical sequence of the Sabin 1 and
ahoney strain).
Discussion. Prolonged poliovirus replication and shed-
ing over a period of 5.5 years were documented by 44
irus isolates and their neutralization by type 1-specific
ntisera. Intratypic serodifferentiation gave divergent re-
ults for the first isolate (vaccine-like) and all later iso-
ates (non-vaccine-like). Restriction fragment length anal-
sis for cutting sites of three different enzymes confirmed
he intratypic serodifferentiation with only one enzyme,
hereas the other two enzymes’ cutting site positions
ither were atypical or indicated poliovirus type 2. Al-
hough both intratypic serodifferentiation and restriction
ragment length analyses are in general reliable meth-
ds (17), complete sequencing demonstrated the direct
hylogenetic relationship of the first isolate (IS1) and the
ast isolate (IS2) (Fig. 1). Thus, sequential multiple polio-
irus infections of our index patient were excluded as a
eason for the repeated poliovirus isolations over a pe-
iod of 5.5 years, and a “chronic,” “persistent” poliovirus
nfection was confirmed. So far, prolonged poliovirus
xcretion had been reported only for periods up to 3.5
ears (6, 19) but reinfections had not been completely
xcluded as a reason for repeated poliovirus isolations.
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180 RAPID COMMUNICATIONThe time required for the evolutionary changes be-
ween Sabin 1 strain and IS1 was calculated from the
omplete genomic sequences (5.4 years) and from a part
f the 59NTR sequence (nt. 640–744) that lacks con-
erved secondary structures in order to exclude positive
election (4.2 years). Both results were in good congru-
nce with the case history of the index patient who was
accinated with OPV 4 to 6 years before onset of symp-
oms and isolation of IS1. Thus, evolutionary calculations
onfirmed the clinical suppositions that the source of
FIG. 1. Neighbor-joining phylogenetic tree of the complete genomes
egion (D) of both isolates from the immunodeficient patient (IS1 and I
train (POL2LAN), Sabin 2 strain (PIPOLS2), type 3 Leon/37 (PI3L37), L
APP case), and wild-type poliovirus type 1 isolates from various regions
D) Numbers at branch nodes refer to the number of bootstrapping re
only frequencies .60% are shown).nfection was the application of OPV and that at least 4 aears of unrecognized enteral replication and shedding
f poliovirus must be assumed. Recently, Kew et al. (9)
stimated 9.3 years of prolonged replication of a vac-
ine-derived poliovirus before onset of paralysis. This
stimation was based on VP1/2A (150 bp) sequence data
f isolates obtained in a 189-day period, whereas the
ase history suggested an infection by application of
PV 6.9 years before onset of paralysis (9). With our
P1/2A sequence data, the same strategy also led to an
verestimation of the time between application of OPV
59NTR, (B), the deduced amino acid sequences (C), and the VP1/2A
e 1 Mahoney strain (POL1), Sabin 1 strain (POLIOS1), type 2 Lansing
a-1-b (attenuated) (PIPOX3), Accession No. AF083938 (isolated from a
world (Accession Nos. AF083939–AF083944 and AJ007964–AJ007965).
s (of 100 performed) at which the distal sequences grouped together(A), the
S2), typ
eon 12
of the
petitionnd onset of symptoms (7.7 years) compared to the case
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181RAPID COMMUNICATIONistory (4 to 6 years). Hence, it may be concluded that
stimating the time since infection from synonymous
hird-codon mutations of the VP1/2A region (150 bp) is
ot an adequate strategy, and other parts of the genome
hould be preferred for this purpose. In contrast to esti-
ating the time since infection, VP1/2A sequence data
roved to be useful for genotyping poliovirus type 1
solates (13, 14) and demonstrated that our isolates were
ore different from various field isolates of wild-type
oliovirus (type 1) than from the Sabin 1 vaccine strain
Fig. 1D).
Both IS1 and IS2 had reverted at nt 480 and nt 6203,
hich is typical for revertants isolated from vaccine-
ssociated poliomyelitis (5) although both mutations
ave only a minor effect on the attenuation phenotype
11). However, both IS1 and IS2 had mutations at nt 935,
t 2438, and nt. 2795, which restored the amino acid
equence of the wild type at three of four determinants of
ttenuation (4). Furthermore, amino acid substitutions
etween Sabin 1, IS1, and IS2 clustered in a region
FIG. 2. Predicted secondary structures of the 59NTR of IS2. Starting fro
hat occurred during the evolution of the isolates IS1 (residues indica
01/102 and 265/266 of poliovirus 1 Sabin are not base-paired. Reversi
S1/IS2 are indicated in red. The calculated free energy of domains IIm poliovirus type 1 Sabin (residues indicated in green), nucleotide exchanges
ted in blue) and IS2, respectively, are presented. Note that the nucleotides
ons to the wild-type sequence at nucleotide positions 21, 26, 356, and 481 ofontaining the NAg I (Fig. 3). In contrast to NAg I, theTABLE 1
Percentage of Genomic Mutations and Resulting Amino Acid Sub-
titutions in Various Regions of the Poliovirus Genome during 5.5
ears of Persistent Enteral Replication: Comparison of IS1 (AJ132960)
nd IS2 (AJ132961)
Genome
region Nucleotides
Percentage of
genomic
mutations
Percentage of
amino acid
substitutions
59NTR 0001–0744 4.43 (n 5 33)
VP4 0745–0951 7.24 (n 5 15) 4.35 (n 5 3)
VP2 0952–1767 4.90 (n 5 40) 1.47 (n 5 4)
VP3 1768–2481 5.88 (n 5 42) 2.52 (n 5 6)
VP1 2482–3387 5.96 (n 5 54) 3.64 (n 5 11)
P2A 3388–3834 6.04 (n 5 27) 4.02 (n 5 6)
P2B 3835–4125 3.78 (n 5 11) 1.03 (n 5 1)
P2C 4126–5112 4.96 (n 5 49) 2.43 (n 5 8)
P3A 5113–5373 4.59 (n 5 12) 2.29 (n 5 2)
P3B 5374–5439 10.61 (n 5 7) 0
P3C 5440–5988 4.19 (n 5 23) 1.09 (n 5 2)
P3D 5989–7371 4.77 (n 5 66) 0.86 (n 5 4)
39NTR 7372–7442 0.15 (n 5 1)
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182 RAPID COMMUNICATIONomplex antigenic sites NAg II and NAg III, which consist
f residues on VP1 (see Fig, 3) and either VP2 (NAg II) or
P3 (NAg III) (12), were almost completely conserved.
robably, IS1 and IS2 were still neutralized by poliovirus
ype 1-specific antisera due to their conserved NAg II
nd NAg III despite their NAg I mutations. These results
ndicate the positive selection of mutants at NAg I, by
olio 1-specific neutralizing antibodies contained in the
mmunoglobulin substitution, by the patient’s intact cyto-
oxic T-cell response, or by an increased virulence of the
utants for human cells. Our hypothesis on positive
election at the NAg I site is in good agreement with the
bservations made by Kew et al. (9) during 189 days of
rolonged poliovirus replication and the significant se-
uence divergence of the Sabin 1 and Mahoney strain at
he NAg I site (Fig. 3). However, the high evolution rate
bserved by us in the VP4 region seems to be quite
nique and must be confirmed in future cases of pro-
onged enteral replication of poliovirus before any con-
lusions should be drawn.
The 59NTR of poliovirus contains highly conserved
econdary structures that are involved in the initiation of
FIG. 3. VP1 amino acid substitutions shown by alignment of the Sab
atient (IS1, IS2) and the Mahoney strain of poliovirus type I (POL1). Po
or VP1. Boldface letters indicate NAg I (1091–1102) and VP1 parts of tositive-strand RNA synthesis and translation. Predic- iions of the secondary structures indicate that about 51%
f the nucleotides in this genome region are base-paired
nd therefore not subjected to genetic drift. Accordingly,
ost nucleotide exchanges of IS1 and IS2 accumulate in
ingle-stranded parts of the 59NTR, often in the short
egion spanning the RNA domains and the start codon.
owever, certain mutations (e.g., nt 102 and 265) seem to
e advantageous as judged from an increase of the
alculated free energy of the putative secondary struc-
ures II and IV due to two additional base pairs in each
omain (Fig. 2).
In conclusion, our results demonstrated the longest
eriod (5.5 years) of poliovirus evolution and shedding by
n immunodeficient patient. Furthermore, phylogenetic
ata suggested an additional 4 to 6 years of unrecog-
ized poliovirus shedding before onset of paralysis. As
ypogammaglobulinemic immunodeficient (e.g., CVID)
atients depend on continuous medical care for their
ong-term survival, prolonged poliovirus excretion seems
o be a problem in developed countries. A systematic
creening of these patients should be discussed as part
f poliovirus eradication efforts. In addition, the use of
ccine strain (POLIOS1; line 1), both isolates from the immunodeficient
on the protein are indicated by a four-digit code. The first digit stands
plex Nag II (1221–1226) and the complex NAg III (1287–1292) (9, 12).in 1 va
sitionsnactivated poliovirus vaccine instead of OPV in devel-
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183RAPID COMMUNICATIONped countries should prevent future cases of vaccine-
ssociated prolonged poliovirus excretion and evolution
oward a wild-type-like genotype. Fortunately, there have
ot been any reports of an increased incidence of VAPP
n countries with a high prevalence of human immuno-
eficiency virus (HIV) infections so far. In HIV patients,
he production of neutralizing antibodies is less impaired
han in CVID, and neutralizing antibodies were detected
n HIV-infected children after the application of OPV,
lthough titers were lower than in HIV-negative children
15). These observations suggest a comparatively low
isk of prolonged poliovirus shedding from HIV-infected
ndividuals. However, production of neutralizing antibod-
es is impaired in advanced stages of acquired immuno-
eficiency syndrome, and future studies on prolonged
oliovirus excretion from HIV-infected patients are re-
uired.
Materials and Methods. Case history. In 1987, a 4-year-
ld male child was diagnosed with CVID after a history of
ultiple sinusitidae and pneumoniae, one of these with
oncomitant meningitis. Quantitative immunoglobulin
Ig) analysis showed IgM ,6 mg/dl, IgG ,250 mg/dl, and
gA ,1 mg/dl. His status improved under ambulant treat-
ent with immunoglobulin substitution. In October 1990,
e developed a paresis of the left arm and both legs
ithin 4 days. Poliomyelitis anterior was suspected, and
oliovirus type 1 was isolated from a throat wash and
eces. Poliovirus was propagated from 43 serial feces
amples until April 1996. Poliovirus excretion had
topped spontaneously in November 1996, and later po-
iovirus isolations were all negative. Because of lack of
linical impact, neuropathogeny of isolates was not eval-
ated in vivo. The patient had a history of three doses of
rivalent OPV application in 1984 to 1986. There was
either a known contact with a polio patient nor travel to
n endemic region for poliovirus. However, contact with
PV vaccinees cannot be excluded between 1986 and
990.
Virus Isolation and Typing. Poliovirus was isolated
rom a throat wash and 43 serial stool samples of the
atient by standard methods and passaged once on
Ep2 cell monolayers (1). Isolates were typed in neutral-
zation tests with hyperimmune equine sera. Antigenic
haracterization was performed by the method of van
ezel (18). Two isolates were chosen for complete se-
uencing. The first isolate was taken from a throat wash
n October 1990, and the last isolate was taken from
eces in April 1996.
Reverse Transcription and Amplification of Poliovirus
enomes. Briefly, poliovirus RNA was purified from cell
ulture supernatants by extraction with unbuffered phe-
ol/chloroform and an additional proteinase K digestion.
everse transcription reaction was carried out with 1
mol primer (2883B, 59-GTAACCACAAAGGTAAGTTCC- o9, 4490B, 59-CATACTGGTTCAATACG-39, 7387B, 59-AAT-
CGACTGAGGTAGGG-39, or an oligo(dT) primer) and
Superscript 2” reverse transcriptase (Life Technologies,
aithersburg, MD). PCRs were performed using the Ex-
and High Fidelity PCR System (Boehringer, Mannheim,
ermany) and four different primer pairs (0001A, 59-TTA-
AACAGCTCTGGGGTTG-39, and 2883B; 2396A, 59-
GTTTTGTGTCAGCG-39, and 4490B; 4030A, 59-CTGGC-
CTTCTTGGGTG-39, and 7387B; and 6987A, 59-TGGT-
ATGATGTAATTGC-39, and an oligo(dT) primer). For
omplete amplification of the 59 end of the cDNA, “an-
hored” RT-PCR was performed using the 59/39 RACE Kit
Boehringer) with the primers provided in the kit and the
ollowing poliovirus-specific primers: 0603B, 59-ATTGT-
ACCATAAGCAGCCA-39, for reverse transcription, and
420B, 59-TTCAGGGGCCGGAGGA-39, for anchored PCR.
ll amplicons were purified by preparative 1.5% agarose
el electrophoresis followed by extraction with the Qia-
en Gel Purification Kit (Qiagen, Hilden, Germany).
Nucleic Acid Sequencing. Both strands of the PCR
mplicons were cycle-sequenced with rhodamine-la-
eled dideoxynucleotide chain terminators (DNA Se-
uencing Kit, ABI, Foster City, CA) and analyzed on an
BI-Prism 310 automatic sequencer. Sequencing prim-
rs were identical to PCR primers. Additional sequenc-
ng primers were selected by the “primer walking”
trategy.
Analysis of Sequence Data. Sequence data were linked
o complete genomic sequences of IS1 (EMBL Acces-
ion No. AJ132960) and IS2 (AJ132961) with the help of
he DNASIS version 6.0 software (Hitachi, Olivet, France).
estriction fragment length polymorphism data were cal-
ulated for the genomic region between nucleotides
402 and 2881 and the cutting positions of the restriction
nzymes DdeI, HaeIII, and HpaII, as proposed by Balan-
nt et al. (3). Complete genomic sequences were aligned
ith EMBL databank sequences with help of the FASTA
nternet server (EBI, Hinxton Hall, UK) in order to search
or homologous sequences. The ClustalW Internet server
EBI) was used for multiple alignments of IS1 and IS2
equences with poliovirus databank sequences. Evolu-
ionary distances were calculated using the two-para-
eter method of Kimura (10) with the programs DNA-
IST, PROTDIST, and NEIGHBOR, and bootstrap resam-
ling was applied to the neighbor-joining trees with the
rograms SEQBOOT and CONSENSE of the PHYLIP 3.5c
rogram package (7). RNA secondary predictions are
ased on a modified prediction of the PV3 59NTR by
kinner et al. (16) and phylogenetic sequence compari-
ons (20). Free energy calculations of predicted RNA
omains were performed with the MFOLD program (ver-
ion 3.0) (21). Since phylogenetic conservation of the
utative secondary structures had high priority, no at-
empt has been made to minimize the energy of the
verall structure.
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